Dr. Peter A. Kouides, MD

Dr. Kouides practices at Rochester General Hospital in Rochester, New York, part of Rochester Regional Health.

Dr. Kouides' NPI, 1780638775, was assigned on May 22, 2006. Dr. Kouides graduated from SUNY Upstate Medical University in 1986. Dr. Kouides holds New York license 177729.

Dr. Kouides' primary practice is Rochester General Hospital, at 1425 Portland Avenue, Rochester, NY 14621 in Monroe County. The practice phone is (585) 922-4000.

Dr. Kouides' primary practice is Rochester General Hospital in Rochester, New York, part of Rochester Regional Health. Dr. Kouides is also affiliated with Unity Hospital. The medical group on file is Rochester General Hospital. Dmand AI also links Dr. Kouides to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kouides practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kouides' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kouides is board certified in hematology by the American Board of Internal Medicine. Dr. Kouides is licensed in New York.

Dmand AI lists chronic anemia, chronic embolism thrombosis, chronic leukemia, deep vein thrombosis (DVT), lymphoma and multiple myeloma among the conditions Dr. Kouides treats.

CMS data shows 161 Medicare services from Dr. Kouides across 6 procedure codes in 2024, for 120 Medicare patients. Medicare paid $11,666 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 120 Medicare patients who saw Dr. Kouides in 2024. The largest group is 65 to 74, with 49 patients. 73% of them have high blood pressure, and 62% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kouides' median patient age at 69, with 59% women.

In 2024, Dr. Kouides wrote 229 Medicare Part D claims for 84 patients. 38% of them were for generic drugs. CMS names the drug for 152 of them, across 6 drugs with 11 or more claims each, at $491,953 in total drug cost. In 2023, CMS named 203 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Kouides for performance year 2024, reported through an alternative payment model (APM). Dr. Kouides accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kouides as offering telehealth.

Dmand AI links 166 papers to Dr. Kouides, published from 2009 to 2025. 2021 was the busiest year, with 14. The most frequent topics are von Willebrand Diseases, von Willebrand Factor and Menorrhagia. Dr. Kouides has published most often in Haemophilia. Dr. Kouides' most frequent co-authors are Robert Sidonio, MD, Andra H. James, MD and Margaret V. Ragni, MD.

Dmand AI links Dr. Kouides to 6 clinical trials. 2 are still active or recruiting. Conditions studied include Hemophilia A, Coagulation Protein Disorders and Hemophilia B. American Thrombosis and Hemostasis Network sponsors the most, 2.

CMS Open Payments shows 54 general payments to Dr. Kouides from 20 drug and device companies from 2016 to 2024. Travel and lodging make up the largest share, 39% of the total. Baxalta US Inc paid the most, $6,729.

Dmand AI lists 1 award for Dr. Kouides.

Dr. Kouides graduated from SUNY Upstate Medical University in 1986.

Dr. Kouides is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.